WVE - Wave Life Sciences Ltd.
IEX Last Trade
5.74
0.030 0.523%
Share volume: 377,974
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$5.71
0.03
0.53%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-12 | 2022-08-11 | 2022-11-10 | 2023-03-23 | 2023-05-03 | 2023-08-03 | 2023-11-09 | 2024-03-06 | |
| Assets | |||||||||
| Total Assets | 167.359 M | 213.319 M | 181.511 M | 146.386 M | 267.270 M | 229.985 M | 199.918 M | 274.949 M | |
| Current Assets | 124.383 M | 160.114 M | 131.434 M | 98.537 M | 219.591 M | 184.708 M | 158.572 M | 235.373 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 12.670 M | 11.951 M | 9.436 M | 10.040 M | 12.029 M | 11.734 M | 11.630 M | 13.936 M | |
| Short Term Investments | 12.670 M | 11.951 M | 9.436 M | 10.040 M | 12.029 M | 11.734 M | 11.630 M | 13.936 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 7.000 M | 21.086 M | |
| Current Cash | 111.713 M | 148.163 M | 121.998 M | 88.497 M | 207.562 M | 172.974 M | 139.942 M | 200.351 M | |
| Total Non-current Assets | 42.976 M | 53.205 M | 50.077 M | 47.849 M | 47.679 M | 45.277 M | 41.346 M | 39.576 M | |
| Property Plant Equipment | 21.046 M | 19.808 M | 18.552 M | 17.284 M | 16.005 M | 14.983 M | 13.770 M | 13.084 M | |
| Other Assets | 685.000 K | 955.000 K | 44.000 K | 62.000 K | 1.176 M | 1.821 M | 155.000 K | 156.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 167.359 M | 213.319 M | 181.511 M | 146.386 M | 267.270 M | 229.985 M | 199.918 M | 274.949 M | |
| Total liabilities | 159.538 M | 174.498 M | 178.156 M | 183.603 M | 294.110 M | 273.831 M | 232.530 M | 227.445 M | |
| Total current liabilities | 58.486 M | 64.082 M | 64.259 M | 71.521 M | 132.566 M | 140.226 M | 99.980 M | 186.440 M | |
| Accounts Payable | 9.853 M | 11.168 M | 15.934 M | 16.915 M | 11.906 M | 12.379 M | 12.608 M | 12.839 M | |
| Other liabilities | 77.435 M | 75.256 M | 80.230 M | 79.964 M | 131.010 M | 104.730 M | 105.380 M | 15.601 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 77.435 M | 75.256 M | 80.230 M | 79.964 M | 131.010 M | 104.730 M | 105.380 M | 15.601 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 7.821 M | 38.821 M | 3.355 M | -37.217 M | -26.840 M | -43.846 M | -32.612 M | 47.504 M | |
| Common stock | 60.517 M | 66.479 M | 93.900 M | 94.527 M | 102.057 M | 105.462 M | 106.025 M | 110.845 M | |
| Retained earnings | -843.328 M | -884.624 M | -923.628 M | -967.337 M | -994.742 M | -1.016 B | -1.009 B | -1.025 B |